ASHWIN PATKAR: Open Payments
NPI 1376627265 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,231 in 250 payments from 22 companies in 2025. Trend: 2023 $3,770 · 2024 $3,070 · 2025 $4,231
Food & beverage: $4,231
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 70 | $890 |
| Axsome Therapeutics, Inc. | 18 | $376 |
| Otsuka America Pharmaceutical, Inc. | 17 | $355 |
| Teva Pharmaceuticals USA, Inc. | 19 | $313 |
| LivaNova USA, Inc. | 7 | $257 |
| Neurocrine BioSciences, Inc. | 21 | $236 |
| Lundbeck LLC | 6 | $232 |
| Indivior Inc. | 17 | $222 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $204 |
| E.R. Squibb & Sons, L.L.C. | 11 | $201 |
Products named: VRAYLAR, REXULTI, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, INGREZZA, SUBLOCADE, CAPLYTA, COBENFY, Auvelity.
Industry payments across NC — which companies pay providers there.
